AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 293: E776-E782, 2007. First published June 5, 2007; doi:10.1152/ajpendo.00481.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/E776    most recent
00481.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tessari, P.
Right arrow Articles by Kiwanuka, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tessari, P.
Right arrow Articles by Kiwanuka, E.

Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study

Paolo Tessari, Anna Coracina, Lucia Puricelli, Monica Vettore, Alessandra Cosma, Renato Millioni, Diego Cecchet, Angelo Avogaro, Antonio Tiengo, and Edward Kiwanuka

Department of Clinical and Experimental Medicine, Metabolism Division, University of Padova, Padua, Italy

Submitted 8 September 2006 ; accepted in final form 17 May 2007

Nitric oxide (NO) is a key regulatory molecule with wide vascular, cellular, and metabolic effects. Insulin affects NO synthesis in vitro. No data exist on the acute effect of insulin on NO kinetics in vivo. By employing a precursor-product tracer method in humans, we have directly estimated the acute effect of insulin on intravascular NOx (i.e., the NO oxidation products) fractional (FSR) and absolute (ASR) synthesis rates in vivo. Nine healthy male volunteers were infused iv with L-[15N2-guanidino]arginine ([15N2]arginine) for 6 h. Timed measurements of 15NOx and [15N2]arginine enrichments in whole blood were performed in the first 3 h in the fasting state and then following a 3-h euglycemic-hyperinsulinemic clamp (with plasma insulin raised to {approx}1,000 pmol/l). In the last 60 min of each experimental period, at {approx}steady-state arginine enrichment, a linear increase of 15NOx enrichment (mean r = 0.9) was detected in both experimental periods. In the fasting state, NOx FSR was 27.4 ± 4.3%/day, whereas ASR was 0.97 ± 0.36 mmol/day, accounting for 0.69 ± 0.27% of arginine flux. Following hyperinsulinemia, both FSR and ASR of NOx increased (FSR by {approx}50%, to 42.4 ± 6.7%/day, P < 0.005; ASR by {approx}25%, to 1.22 ± 0.41 mmol/day, P = 0.002), despite a {approx}20–30% decrease of arginine flux and concentration. The fraction of arginine flux used for NOx synthesis was doubled, to 1.13 ± 0.35% (P < 0.003). In conclusion, whole body NOx synthesis can be directly measured over a short observation time with stable isotope methods in humans. Insulin acutely stimulates NOx synthesis from arginine.

arginine; 15N nitrates; precursor pool; gas chromatography-combustion-isotope ratio mass spectrometry



Address for reprint requests and other correspondence: P. Tessari, Dept. of Clinical and Experimental Medicine, Metabolism Division, Policlinico Universitario, via Giustiniani 2, 35128 Padua, Italy (e-mail: paolo.tessari{at}unipd.it)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.